Table 3.
Pathology results of patients in the EBUS-GS and ENB-EBUS groups
| Category | EBUS-GS (n, %) | ENB-EBUS (n, %) | P Value |
|---|---|---|---|
| Malignant | 58/65 (89.2) | 4/17 (23.5) | 0.00 |
| Endocrine cancer | 1 (12.5) | 0 | 1 |
| Adenocarcinoma | 45 (77.6) | 3 (75) | 1 |
| Squamous cell carcinoma | 3 (5.2) | 1 (25) | 0.239 |
| Small cell lung cancer | 4 | 0 | |
| Unclassified lung cancer | 1 | 0 | |
| Carcinoid | 1 | 0 | |
| Sarcomatoid carcinoma | 1 | 0 | |
| Metastasis | 2 | 0 | |
| Benign | 7/65 (10.8) | 13/17 (76.5) | 0.00 |
| Tuberculosis | 2 (28.6) | 5 (38.5) | 1 |
| Chronic inflammation | 4 (57.1) | 6 (46.2) | 1 |
| Hamartoma | 0 | 1 | |
| Mycotic infection | 1 | 1 |
Note that the difference in the proportion of malignant or benign diseases between the two groups of patients was statistically significant.